Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
USGLC Highlights Public-Private Partnership That Supports Refugees In South Sudan

U.S. Global Leadership Coalition: A Public-Private Partnership that’s Saving Refugees and Rescuing Aid Workers David Stein, policy associate at USGLC, marks Global Partnership Week and discusses how “forward-thinking businesses and nonprofits have been working with the U.S. government in innovative ways to tackle some of the toughest challenges in global…

Collaboration, Partnership Among Many Sectors Can Improve Health Access Worldwide

Huffington Post: Hurdling the Health Access Barrier Cassie Chandler, global manager of microfinance and health protection at Freedom from Hunger “…Whether in Asia, Latin America, or Africa, one of the most significant barriers to good health is being able to access health services in a timely manner. There are a…

Second Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part II In part two of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores the challenges China faced in marketing its artemisinin-based combination therapies worldwide. “…The 2004-2006 artemisinin bubble nevertheless has not…

U.S. Trade Policies Threaten To Undermine Successful Global Health Programs

The Hill: U.S. trade policy could raise drug prices, at home and abroad Rep. Jan Schakowsky (D-Ill.) and Peter Maybarduk, director of Public Citizen’s Global Access to Medicines program “…[With the creation of PEPFAR, t]he United States put public health needs ahead of pharmaceutical industry profits and made a transformative…

Passage Of ‘Innovation Act’ By Congress Would Harm Drug Development

Roll Call: The Wrong Direction on Patents Todd E. Gillenwater, senior vice president of Public Policy at the California Healthcare Institute “…Poorly conceived and hastily written legislation can stunt innovation, harm the economy, and even cost lives. Unfortunately, this is the case with the recently reintroduced Innovation Act (H.R. 9).…

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…

Experimental Ebola Drug Shows Promise In Treating Early Infection, Study Shows

Agence France-Presse: Limited promise in early results from Ebola drug trial “Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed it was somewhat effective at saving lives if given early in the illness, but not later…” (2/23). Reuters: Ebola drug in Guinea helps some, stirs debate…